Mark James Litton

Insider Reports History

Entity
Individual
Location
11804 North Creek Parkway South, Bothell, WA
Signature
/s/ Mark Worthington, Attorney-in-Fact for Mark James Litton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark James Litton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Athira Pharma, Inc. President and CEO, Director Restricted Stock Units 325K $184K $0.57 Oct 3, 2024 Direct
Athira Pharma, Inc. President and CEO, Director Common Stock 159K $90.2K $0.57 Sep 5, 2024 Direct
Athira Pharma, Inc. President and CEO, Director Common Stock 6.56K $3.71K $0.57 Sep 3, 2024 By Irrevocable Trust of OSL
Athira Pharma, Inc. President and CEO, Director Common Stock 6.56K $3.71K $0.57 Sep 3, 2024 By Irrevocable Trust of SWL
Athira Pharma, Inc. President and CEO, Director Common Stock 6.56K $3.71K $0.57 Sep 3, 2024 By Irrevocable Trust of WGL
Athira Pharma, Inc. President and CEO, Director Stock Option (Right to Buy) 325K Oct 3, 2024 Direct

Insider Reports Filed by Mark James Litton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATHA Athira Pharma, Inc. Oct 3, 2024 1 $0 4/A Oct 3, 2024 President and CEO, Director
ATHA Athira Pharma, Inc. Sep 3, 2024 2 -$2.85K 4 Sep 5, 2024 President and CEO, Director
ATHA Athira Pharma, Inc. Feb 15, 2024 1 $0 4 Feb 16, 2024 CEO, Director
ATHA Athira Pharma, Inc. Jan 4, 2024 2 -$14K 4/A Feb 16, 2024 CEO, Director
ATHA Athira Pharma, Inc. Jan 4, 2024 2 -$14K 4 Jan 8, 2024 Chief Executive Officer, Director
ATHA Athira Pharma, Inc. Jan 27, 2023 2 $1.81K 4 Jan 31, 2023 Chief Executive Officer, Director
ATHA Athira Pharma, Inc. Jun 22, 2022 3 -$16.1K 4 Jun 24, 2022 Chief Executive Officer, Director
ATHA Athira Pharma, Inc. Jan 27, 2022 2 $11.1K 4 Jan 31, 2022 Chief Executive Officer, Director
ATHA Athira Pharma, Inc. Aug 17, 2021 3 $80.6K 4 Aug 19, 2021 Chief Operating Officer